Fluconazole 200mg injection recalled due to sterility concerns
Sentara Infusion Services is recalling Fluconazole 200mg injectable solution due to lack of sterility assurance. The recall affects 13 bags distributed nationwide to patients.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable drug with lack of sterility assurance, representing a risk-of-harm product where no illnesses or injuries have been reported. The hazard is theoretical but potentially serious due to direct-to-bloodstream administration.
Plain-English summary
Sentara Infusion Services is recalling Fluconazole 200mg NS 100ml (an antifungal injectable medication) due to lack of sterility assurance. The product is an intravenous infusion used to treat fungal infections and is available by prescription only.
The recall involves 13 bags of the product that were dispensed directly to patients nationwide. The Beyond Use Date for the affected product is December 2-31, 2022. Sterility assurance is critical for injectable medications because any microbial contamination could potentially cause serious infections when administered directly into the bloodstream.
Patients who received this product should contact their healthcare provider or pharmacist immediately. Consumers should not use any remaining supply of this product. Healthcare providers should review patient records to identify anyone who may have received the recalled medication and take appropriate follow-up actions.
The recalled product
- Product
- FLUCONAZOLE 200MG NS 100ML, antifungal, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
- Manufacturer
- Sentara Infusion Services
- Category
- Drug — Injectable / Infusion
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Beyond Use Date: December 2-31
- 2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27